Sanjana Manja, M.S.

Sanjana Manja is a Principal Associate Scientist within the Translational Biology Team at Strand Therapeutics. In her role, she will be executing in vivo and ex vivo oncology studies to support pre-clinical development efforts. She will also be executing multiparameter spectral flow cytometry assays to analyze the response of immune cells for drug discovery. Prior to Strand, Sanjana was a Senior Research Associate at SQZ Biotechnologies, where she worked on developing mRNA-based cell therapy for HPV-16 positive tumors. Being a key contributor in IND-enabling studies at her previous company, she brings extensive expertise in cell and product characterization via Flow cytometry along with other luminescent/ luciferase-based assays. She is experienced in designing and performing functional assays to characterize immune cells. She also brings 4+ years of experience in in vivo handling, rodent behavior studies, as well as ex vivo studies. Sanjana received her Master’s in Biotechnology with a Thesis track from University of Central Florida and holds a Bachelor’s in Biotechnology Engineering.